To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies
Clinical trial NCT01788813 · COMPLETED
Trial details
- NCT number
- NCT01788813
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-08-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.